US FDA Expands Approval of Johnson & Johnson Drug for Rare Blood Disorder
WASHINGTON, Aug 25: The US Food and Drug Administration has expanded the approved use of a Johnson & Johnson medicine for patients suffering from a rare blood disorder, the company said Monday.
The regulatory decision broadens the treatment options available to people affected by the condition and could allow more patients to receive the…
Read More...